Cochlear | COH - Selling And Administration Expenses

Stock Price
96.33
Daily Change
0.91 0.95%
Monthly
-43.27%
Yearly
-64.11%
Q2 Forecast
98.03

Cochlear reported AUD449.4M in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
Ansell USD 274.8M 7.6M Dec/2025
Avita Medical AUD 19.03M 1.95M Dec/2025
Cochlear AUD 449.4M 214.45M Dec/2025
CSL USD 1.23B 498M Dec/2025
Fisher Paykel Healthcare NZD 285.5M 11.6M Dec/2025
Healius AUD 393.4M 378.35M Dec/2024
Integral Diagnostics AUD 169.98M 18.73M Jun/2024
Mayne Pharma AUD 54.8M 11.94M Jun/2024
Mesoblast USD 28.54M 9.69M Dec/2025
Monash IVF AUD 33.08M 26.76M Dec/2025
Nanosonics AUD 53.78M 26.93M Dec/2025
Polynovo AUD 17.04M 1.91M Dec/2025
Ramsay Health Care AUD 5.29B 3.2M Dec/2024
Regis Healthcare AUD 61.19M 6.96M Dec/2025
ResMed USD 275.7M 16.51M Dec/2025
Sigma Healthcare AUD 134.77M 9.73M Dec/2024
Somnomed AUD 19.5M 353.23K Jun/2023
Sonic Healthcare AUD 2.52B 2.46B Dec/2024
Telix Pharmaceuticals AUD 93.48M 1.04M Dec/2025